Compare Danaher Corporation (DHR) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs The Coca-Cola Co K — how do they compare? Danaher Corporation trades at $218.41 (market cap $152.87B), while The Coca-Cola Co K trades at $87.34 (market cap $377.63B). The key difference: The Coca-Cola Co K is far larger — about 2.5× Danaher Corporation's market cap, and The Coca-Cola Co K pays the higher dividend (2.42%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and The Coca-Cola Co K for 154 Days on average.
| DHR | KO | |
|---|---|---|
Market Cap | $152.87B | $377.63B |
Volume | 5,228,698 | 14,894,568 |
Sector | Health | Consumer Staples |
52-Week High | $242.05 | $91.99 |
52-Week Low | $161.91 | $66.37 |
Typical Hold Time | 69 Days | 154 Days |
Enterprise Value | $175.08B | $404.81B |
Dividend Yield | 0.74% | 2.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Coca-Cola (KO) trades at $85.82, down 0.41% on the day, with technical indicators showing bearish momentum despite strong fundamentals. The company reported consistent earnings beats in recent quarters with Q2 2026 EPS of $0.97 beating expectations of $0.92. Revenue growth remains steady at $47.94B for 2025, with net income margin improving to 28.56%. Analyst consensus remains bullish with a $95.75 price target, representing 11.6% upside potential from current levels.
The stock presents a compelling dividend opportunity with 64 consecutive years of dividend increases, though technical weakness and regional demand divergence pose near-term risks. Long-term investors may find value in the company's stable cash flows and global brand strength, while short-term traders should monitor support at $85 for potential entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
